ResponseAccess to needle and syringe programs by people who inject image and performance enhancing drugs
References (16)
- et al.
Performance and image enhancing drug injectors’ access to needle syringe programs: Responding to a public policy dilemma
International Journal of Drug Policy
(2015) - et al.
Risk and vulnerability among people who inject image and performance enhancing drugs in England and Wales 2012–2013: Where should we focus harm reduction?
- et al.
Blood-borne virus prevalence and risk among steroid injectors: Results from the Australian Needle and Syringe Program Survey
Drug and Alcohol Review
(2008) - et al.
Prevalence of, and risk factors for, HIV, hepatitis B and C infections among men who inject image and performance enhancing drugs: A cross-sectional study
BMJ Open
(2013) - et al.
Injection site infections and injuries in men who inject image- and performance-enhancing drugs: Prevalence, risks factors, and healthcare seeking
Epidemiology & Infection
(2015) - et al.
Are people who inject performance and image-enhancing drugs an increasing population of Needle and Syringe Program attendees?
Drug and Alcohol Review
(2013) - et al.
Estimating the cost-effectiveness of needle–syringe programs in Australia
AIDS
(2012)
There are more references available in the full text version of this article.
Cited by (0)
© 2016 Elsevier B.V. All rights reserved.